リアルワールドの臨床コホートにおける頭頸がんの診断と治療後の脳卒中リスク: ランニングタイトル: リアルワールドの臨床コホートにおける治療
Preeti Bhagia1, Amrita Mukherjee2, Tijil Agarwal3
1Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, United State.
Oral oncology
|September 2, 2025
まとめ
頭頸部がんの患者は 脳卒中のリスクがかなり高く 一般人よりほぼ2倍です 喫煙,高齢化,高血圧や糖尿病などの併発性疾患は 総合的なケアを必要とする 重要なリスク要因です
科学分野:
- 腫瘍学
- 心血管医学
- 流行病学
背景:
- 頭頸部がん (HNC) の患者は,一般患者と比較して脳卒中のリスクが高くなります.
- このリスクを理解し軽減することは 患者の治療結果を改善するために不可欠です
研究 の 目的:
- 頭頸部がん患者の大群で脳卒中の発生率と危険因子を調査する.
- 脳卒中のリスクの増加に関連する特定の患者のサブグループと治療方法を特定する.
主な方法:
- 米国280のがんセンター (2003年−2019年) の8469人の頭頸がん患者の電子医療記録 (EMR) を利用した.
- 様々なリスク因子の年齢調整された脳卒中発生率と危険比率を計算するためにポアソン回帰を用いた.
- 年齢,喫煙状況,治療方法 (放射線治療,化学療法),併発性疾患 (高血圧,糖尿病) を考慮したデータを分析した.
主要な成果:
- 頭頸部がん患者では,年齢調整による脳卒中の発生率が一般患者より1. 7倍 (307対184人/年) であった.
- 喫煙者の脳卒中発生率は10万人当たり445.1人であり,診断後1年以内に発症した脳卒中の割合は93.94%であった.
- 高齢患者 (> 60歳),放射線治療を受けている患者,高血圧患者 (3. 6倍増加したリスク) または高血圧患者および糖尿病患者 (7. 4倍増加したリスク) は,脳卒中のリスクが著しく高かった.
結論:
- 頭頸部がん患者,特に喫煙者,高齢者,高血圧および/または糖尿病の患者は,脳卒中のリスクが大幅に増加しています.
- 放射線治療は,化学療法のみと比較して,より高い脳卒中発生率と関連している可能性があります.
- 総合的な脳卒中リスク評価と管理を 頭頸部がん患者のフォローアップケアに組み込むことは不可欠です
さらに関連する動画
関連する概念動画
Arteries of the Head and Neck
1.7K
The human body's intricate network of arteries ensures that every organ system receives the necessary oxygen and nutrients for optimal function. The arterial network in the head and neck region is particularly complex, providing vital blood flow to the brain, eyes, and other critical structures. Prominent arteries in this region include the internal carotid arteries and the vertebral arteries.
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
1.7K
Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
Veins of Head and Neck
2.8K
The blood drainage from the head and neck is primarily managed by three pairs of veins: the external jugular, internal jugular, and vertebral veins. The external jugular veins drain superficial scalp and face structures, passing over the sternocleidomastoid muscles to empty into the subclavian veins.
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
2.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Relative Risk
340
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
340
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K


